We are Bio Design Lab, a South Korean startup developing novel retro- and lentiviral vector platforms that are safer than existing vectors and with high transduction efficiency – the foundation of effective gene, cell, and immunotherapies.

With our RetroNext and LentiNext platforms, we are redefining the standards of safety, efficiency, and productivity.

Founded in 2018, our mission is to facilitate and accelerate the development of next-generation biopharmaceuticals for currently incurable diseases.

Bio Design Lab

Org chart

Teams

Offices